alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Federal Register Volume 77, Number 66 (Thursday, April 5, 2012)]
[Notices]
[Page 20646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-8214]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases: 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Translational Research 
in Diabetes and Obesity.
    Date: May 17, 2012.
    Time: 11 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-8214 Filed 4-4-12; 8:45 am]
BILLING CODE 4140-01-P
```
**Exhibit          32.2**

**CERTIFICATION          PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS          ADOPTED PURSUANT TO**

**SECTION          906 OF THE SARBANES-OXLEY ACT OF 2002**

|   | 1. | The                    Report fully complies with the requirements of Section 13(a)                    or 15(d) of                    the Securities Exchange Act of 1934; and |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The                    information contained in the Report fairly presents, in all material                    respects, the financial condition and results of operations of                    the                    Registrant. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                |                                                         |                                |
|-------------------------------------|--------------------------------------------------------------|-------------------------------------|
| Date:                  May 22, 2006 | By:                                                | /s/                  Flemming Munck |
|                                | Name:                  Flemming Munck                        |
|                                | Title:                  Chief Financial Officer and Director |
[Nos. 18318-8-II; 18353-6-II.

Division Two.

July 19, 1996.]

#### Evangelical Lutheran Good Samaritan Society, Inc., et al., *Respondents,*v. The Department of Social and Health Services, *Appellant.*KLR Associates, Inc., et al., *Respondents,*v. The Department of Social and Health Services, *Appellant.*

Appeals from judgments of the Superior Court for Thur-ston County, Nos. 93-2-00582-0 and 93-2-00993-1, Daniel J. Berschauer, J., entered May 11, 1994. *Affirmed in part*and *reversed in part*by unpublished opinion per Morgan, J., concurred in by Seinfeld, C. J., and Armstrong, J.
----

| 1. | The      quarterly report on Form 10-Q of Grande Communications Holdings, Inc. for      the three months ended June 30, 2008 filed on the date hereof with the      Securities and Exchange Commission (the “Report”) fully complies with the      requirements of Section 13(a) or 15(d) of the Securities Exchange Act      of 1934; and |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of Grande      Communications Holdings, Inc. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:      August 8, 2008 |   | /s/    Roy      H. Chestnutt                                  |
|---------------------------|--------|-----------------------------------------------------------------------------------|
|                      |   | Roy      H. Chestnutt                                                             |
|                      |   | President,      Chief Executive Officer and Chairman of the Board of    Directors |

|                      |   |                                               |
|---------------------------|--------|----------------------------------------------------|
|                      |   |                                               |
| Date:      August 8, 2008 |   | /s/    Michael      L. Wilfley |
|                      |   | Michael      L. Wilfley                            |
|                      |   | Chief      Financial Officer                       |

----
Skip to main content (Press Enter).
 Toggle navigation
            
            
            
            U.S. Air Force
                    U.S. Air Force
        Search
                    Search AF.mil:
                        Search
                Search AF.mil:
                    Search
    News
    
        Commentaries

    Features

    Photos

    Art

    Air Force TV

    Radio

    Week in Photos

    Coronavirus Disease 2019

    Air Force Art Collection





    About Us
    
        Air Force Senior Leaders    
        SECAF

    CSAF

    CMSAF

    Biographies

    Adjunct Professors

    Fact Sheets

    Commander's Call Topics    
        CCT Archive

    50 Years of the CMSAF

    The Book

    Speeches Archive    
        Former AF Top 3 Viewpoints and Speeches

    Air Force Warrior Games 2019

    Air Force Strategic Documents

    DoD Warrior Games

    Portraits in Courage    
        Portraits In Courage Vol. I

    Portraits In Courage Vol. II

    Portraits In Courage Vol. III

    Portraits In Courage Vol. IV

    Portraits In Courage Vol. V

    Portraits In Courage Vol. VI

    Portraits In Courage Vol. VII

    Portraits In Courage Vol. VIII

    Portraits In Courage Vol. IX

    Portraits In Courage Vol. X

    Chapman MoH

    The Air Force We Need

    Events 2021

    Focus on Priorities

    Empowered Airmen

    State Licensure Portability

    CSAF Leadership Library    
        CSAF Leadership Library Bookshelf

    2018 CSAF Reading List

    2017 CSAF Reading List

    2016 CSAF Reading List





    AF Sites
    
        Social Media Sites

    Site Registration





    AF Content Management





    Careers





    Contact Us  
 Home
  News
  Photos
 Air Force Photos Search
 Search
 Upload Date Upload DatePhoto DateTitle
  Full Size (1.11 MB)
 Photo Gallery
 Quick Links
                            Join the Air ForceSite MapQuestionsContact UsRSSFOIAIGAF SitesAccessibilityEEOLink DisclaimerStrategic APRSuicide PreventionSAPRUSA.govNo FEAR ActOSI Tip Line
                    Connect
                    Official United States Air Force Website
                        Subscribe to USAF News and Information
          Submit
```

[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 36 Referred in Senate (RFS)]

  2d Session
H. CON. RES. 36

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              June 5, 2002

Received and referred to the Committee on Health, Education, Labor, and 
                                Pensions

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
    Urging increased Federal funding for juvenile (type 1) diabetes 
                               research.

Whereas over one million Americans suffer from juvenile (type 1) diabetes, a 
        chronic, genetically determined, debilitating disease affecting every 
        organ system;
Whereas 13,000 children a year--35 each day--are diagnosed with juvenile 
        diabetes;
Whereas 17,000 adults a year--46 each day--are diagnosed with juvenile diabetes;
Whereas juvenile diabetes is one of the most costly chronic diseases of 
        childhood;
Whereas insulin treats but does not cure this potentially deadly disease and 
        does not prevent the complications of diabetes, which include blindness, 
        heart attack, kidney failure, stroke, nerve damage, and amputations; and
Whereas the Diabetes Research Working Group, a nonpartisan advisory board 
        established to advise Congress, has called for an accelerated and 
        expanded diabetes research program at the National Institutes of Health 
        and has recommended an increase in Federal funding for diabetes research 
        at the National Institutes of Health over each of the next five years: 
        Now, therefore, be it
    Resolved by the House of Representatives (the Senate concurring), 
That Federal funding for diabetes research should be increased annually 
as recommended by the Diabetes Research Working Group so that a cure 
for juvenile diabetes can be found.

            Passed the House of Representatives June 4, 2002.

            Attest:

                                                 JEFF TRANDAHL,

                                                                 Clerk.
```
EXHIBIT 32.2  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of Lotus Pharmaceuticals, Inc. (the Company) on Form 10-QSB/A for the period ended March 31, 2007 as filed with the Securities and Exchange Commission (the Report), I, Adam Wasserman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.  /s/ Adam Wasserman
 Adam Wasserman, Chief Financial Officer
  February 19, 2008  A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the company and will be retained by the company and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 32.1

# CERTIFICATION OF PRINCIPAL
EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Buffets Holdings, Inc. (the Company) on Form
10-Q for the period ending April 6, 2005, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Roe H. Hatlen, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002,
that:

| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the
                    Securities Exchange Act of 1934; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------

| | (2) | The information contained in the Report fairly presents, in all material
                    respects, the financial condition and result of operations of the Company.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 
| | 
|
|
|
|
|
| | 
| | 
|
| | 
| | 
| | 
| |
[Federal Register Volume 77, Number 64 (Tuesday, April 3, 2012)]
[Notices]
[Page 20025]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7915]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0508]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Blood Establishment Registration and 
Product Listing, Form FDA 2830

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Blood Establishment Registration 
and Product Listing, Form FDA 2830'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Information 
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, 
Rockville, MD 20850, 301-796-7726, <a href="/cdn-cgi/l/email-protection#d3babfb2fdbebaa9a1b2b0bbba93b5b7b2fdbbbba0fdb4bca5"><span class="__cf_email__" data-cfemail="b2dbded39cdfdbc8c0d3d1dadbf2d4d6d39cdadac19cd5ddc4">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: On January 4, 2012, the Agency submitted a 
proposed collection of information entitled ``Blood Establishment 
Registration and Product Listing, Form FDA 2830'' to OMB for review and 
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, 
and a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number. OMB has now 
approved the information collection and has assigned OMB control number 
0910-0052. The approval expires on March 31, 2015. A copy of the 
supporting statement for this information collection is available on 
the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: March 28, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-7915 Filed 4-2-12; 8:45 am]
BILLING CODE 4160-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.2
 
 
 
 
 Certification of Principal Accounting
Officer Pursuant to
 Section 906 of the Sarbanes-Oxley Act
of 2002, 18 U.S.C. Section 1350
 
 
 In
connection with the quarterly report on Form 10-Q of Rotoblock Corporation
(Registrant), as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Richard Di Stefano, Principal Accounting Officer, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and
belief:
 
 (1) the
report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 (2) the
information contained in the report fairly presents, in all material respects,
the financial condition and results of operations of Registrant.
 
 
 Date: September
14,
2009 ROTOBLOCK
CORPORATION
 
 /s/ 
Richard Di Stefano
 By:
Richard Di Stefano, Chief Financial Officer/Principal Accounting Officer
My name is Samantha Spaccasi. I am a sophomore at Oberlin College, majoring in Environmental Studies with a concentration in Environmental Justice, and my hometown is Darnestown, MD. I am also the Clean Water intern atthe Sierra Club Maryland Chapter. At school, I campaign againstthe dangerous process oftracking. If it isn't already obvious, protecting the environment is my passion. Iwould like to thank EPAforthis opportunity to testify.
Myfamily roots lie in Hawaii. My great-grandmother, a Korean picture bride, was shipped off to marry mygreat-grandfatherand start a home on the plantation. Growing up, I heard fantastic stories aboutthis beautiful land, with its lush forests, crystal-clear waters, and diverse wildlife. I have had the fortune to visitthis land manytimes, and each time I return there, I am amazed by how much these people care about and workwith the land they live in. Walking offthe airplane, the air immediately smells offlowers, and feels refreshing and healthy. Breathing in Hawaii is unlike breathing anywhere else.

When I come back to Maryland, I immediatelyfeel suffocated. No, it's not because ofthe natural humid climate, it is because "Maryland suffers from the worst air quality on the Atlantic Coast" (MD Beyond Coal Campaign). Only 5 out ofthe 13 coal plants have modern pollution-cutting technologyfor both sulfur dioxide and smog-causing nitrogen oxides. What's most disappointing, however, is that none ofthosefive are using theirtechnologyto the maximum extent possible to reduce pollution! I live a mere 10 miles awayfrom one of my state's dirtiest coal plant, the Dickerson Power Plant, and for 19years I have been breathing the toxic airfrom this power plant. My entire family lives in Maryland. They too have been breathing this dangerous airfor most or all oftheir lives. Butthanks to the good work done bythe EPA, maybe something will finally be done to increase the air quality in my home state.

EPA, I laud you fortaking action on climate change and protecting Americans health while still making it possible to maintain an affordable energy system. Thankyou for seeing that cutting carbon emissions will not hurt oureconomy. These actions are so significant towards taking a step forward in the complic,ated battle ofclimate change. Reducing emissions is important, but also is taking the timeto promote and increase subsidies for renewable energy. Renewables are clean, healthy, and can be adapted to our infrastructure. The installation ofthese healthy energy sources are also sources ofmuchneededjobs. They can also make the US energy independent in a clean, practical way.

I beg you notto bend to the whims ofthe greedy coal industries, intent on increasing profit atthe expense ofthe health ofthousands ofAmericans. These rules proposed are beyond reasonable and practical. Thankyou so much for taking initiative to protect mygeneration's and future generation's ability to breathe easy, and thank you again for allowing methis opportunity to testify before you.
#### Terry L. JOHNSON, Plaintiff, v. INDUSTRIAL COMMISSION OF UTAH; Walter T. Axelgard, Chairman, Stephen M. Hadley, Commissioner; and Milton E. Saathoff, Commissioner, Defendants.

No. 17956.

Supreme Court of Utah.

July 1, 1982.

David Lloyd, Salt Lake City, for plaintiff.

David L. Wilkinson, Atty. Gen., Frank D. Nelson, Asst. Atty. Gen., Salt Lake City, for defendants.

PER CURIAM:

The Commission denied compensation in this case after an evidentiary hearing before an administrative law judge who concluded there was no entitlement under the Workmen’s Compensation Act1 based on the facts adduced.

The plaintiff is a truck driver who, in September, 1979, bumped his head on the cab of his truck in the course of his employment. He testified that it hurt “pretty bad for a second” and later told his employer it was no “biggie.”

Following the accident, the plaintiff suffered from a headache and within several days there developed a loss of balance and paralysis or weakness in his right arm and leg. A Dr. Thoen attended plaintiff and suspected he was suffering multiple sclerosis, which the plaintiff rejected, suggesting it was “all due to my nerves.” The symptoms continued and he saw two eye surgeons and two neurologists. One of them, a Dr. Barbuto, without any definite diagnosis, felt the symptoms would be “compatible with residuals from an old head injury.” In March, 1980, the plaintiff, who claimed he could do only restricted types of work, filed for workmen’s compensation. A medical panel concluded that the bump to his head played no part in his symptomatology. On the panel’s recommendation, spinal tests were performed which confirmed this finding.

It appears that the weight of the evidence in this case does not compel this Court to reverse the administrative law judge’s decision, affirmed by the Commission. On the contrary, the believable proof in this case calls for affirmance under the Act itself2 and under the precedents of this Court.3 The plaintiff’s only support for compensation under the Act came from the suggestions of one neurologist in a non-di*1260agnostic setting. Even he stated that “there is no known way that [plaintiff’s] accident would produce a positive spinal fluid study” and “it would not produce continued evolving symptoms.”

Counsel for the plaintiff calls attention to a wealth of material dealing with “aggravation” cases generally, with which we have no quarrel. None of this material is applicable to the facts of this case, however.

The decision of the Commission denying the award is affirmed.

1

. U.C.A., 1953, 35-1-1, et seq.

2

. U.C.A., 1953, 35-1-84 and -85 which render the facts in such decision conclusive absent prejudicial abuse of discretion.

3

*. Chadwick v. Industrial Commission,*Utah, 572 P.2d 400 (1977); *Chief Consolidated Mining Co. v. Salisbury,*61 Utah 66, 210 P. 929 (1922).
Exhibit 4.2



 






Exhibit 4.2




WESTERN
RESERVE BANCORP, INC.

FORM 10-QSB

June 30, 2005



Legend to be Placed on Certificates Representing Shares Issued in the Offering:



The shares represented by this certificate have not been registered under the Securities Act of
1933 (the “Act”) but have been sold pursuant to an exemption from the registration provisions of
the Act under Section 3(a)(11) of that Act and Rule 147 promulgated thereunder. Such shares may
not be resold outside the State of Ohio for nine (9) months after issuance.
#### Nicholas S. RAICH and Sharon M. Raich, his wife, Appellants, v. MARTHA A. GOTTFRIED, INC., Appellee.

No. 87-1527.

District Court of Appeal of Florida, Fourth District.

April 27, 1988.

Rehearing Denied May 20, 1988.

*1255John L. Bryan, Jr., of Scott, Royce, Harris, Bryan & Hyland, P.A., Palm Beach, for appellants.

Peter S. Broberg of Coe and Broberg, Palm Beach, for appellee.

PER CURIAM.

We affirm, and find no error by the trial court in concluding, based upon the evidence presented at trial, that the appellee real estate broker was entitled to the amount of the commission provided for in the exclusive listing agreement as damages, when the appellants, owners of the property, agreed to sell the property to a third party during the term of the listing agreement. *Cf. Whitehurst v. Erstling,*184 So.2d 233 (Fla. 3d DCA 1966). The trial court found that the appellants intentionally failed to refer the ultimate purchasers to the appellee broker as required by the terms of the listing agreement hence depriving the appellee of the commission provided in the agreement.

ANSTEAD, GLICKSTEIN and GUNTHER, JJ., concur.